Full-Stack Developer
We are seeking a self-driven and passionate software engineer to help develop a software platform to improve the analysis of gene expression sequencing data for research and clinical uses. We are seeking a full-stack developer who can collaborate with a backend engineering team and algorithm developers to help design and launch v1.0 of our cloud platform. (more details …)
Backend Software Developer
We are seeking a self-driven and passionate software engineer to help advance a software platform to improve the analysis of gene expression sequencing data for research and clinical uses. We are seeking a backend developer to enhance, integrate and optimize an existing moderately-sized C++ and Go codebase and who can develop new, efficient software. (more details …)
Computational Biologist
We are seeking a self-driven and passionate computational biologist with experience in genomics and gene expression to drive the development of data analyses for a new web platform for gene expression analyses and to interface with customers to help solve interesting data analysis challenges. (more details …)
Devops Engineer Wanted
We are seeking a self-driven and passionate DevOps engineer to operationalize our existing SaaS genomics analysis platform and to participate in a significant expansion of our cloud-based offerings (more details …)
Ocean provided our platform and expert services required to define approach, review analysis results, and work with partner to revise endpoint. Ocean’s platform produced complete feature extraction, classifier generation, QC and comprehensive reporting on 55 samples (FASTQ) and patient metadata in 19 hours, providing a 24-hour turn-around time with partner.
Novel target discovery in pembrolizumab-resistant gastric cancer using Ocean’s AI-driven transcriptome analysis platform and expert services.
Ocean Genomics is pleased to announce the following individuals have joined our scientific advisory board. Each has significant experience in oncology and adoption of new technologies and techniques involving the study and treatment of cancer.
Ocean Genomics has added 5 leading cancer experts to our scientific advisory board. Each has significant experience in oncology and adoption of new technologies and techniques involving the study and treatment of cancer.
Ocean Genomics Inc., a privately held company, has closed initial financing, led by Ocean Investors, LLC, that will be used to advance its whole-transcriptome analysis platform. The company will expand and support its advanced open-source expression analysis software pipeline while creating commercial enhancements and extensions using artificial intelligence-driven algorithms to deliver client solutions in oncology, in both research and clinical applications.